SR
Sirona Biochem Corp.
SRBCF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $2.25M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 64.82x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 30.97%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 82.71%
Net margin 7,312.43%
FCF margin 5,053.37%
Quality
58 /100
Average ROIC 1,259.21%
ROA 246.42%
Asset turnover 0.03x
Debt
4 /100
High Current ratio 0.55x
Int. coverage -11.62x
Debt/Equity N/A
Stability
25 /100
Unstable Beta -0.07x
Rev. volatility 142.58%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SRBCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howard J. Verrico
Employees
10
Headquarters
Vancouver